A. Heidenreich

Pulmonary and Respiratory Medicine · European Urology · 2001–2020

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Heidenreich trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Billis
  2. Alan W. Partin
  3. Michel Bolla
  4. J. Ferlay
  5. Jonathan I. Epstein

Who trusts A. Heidenreich overall

  1. J. Bellmunt

Papers from A. Heidenreich's perspective

Ordered by how strongly the researchers A. Heidenreich trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Screening and prostate-cancer mortality in a randomized European study. (New England Journal of Medicine)
  2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
  3. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. (New England Journal of Medicine)
  4. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. (Journal of Clinical Oncology)
  5. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. (European Urology)
  6. Comparative effectiveness of minimally invasive vs open radical prostatectomy. (Journal of the American Medical Association (JAMA))
  7. International variation in prostate cancer incidence and mortality rates. (European Urology)
  8. Estimates of cancer incidence and mortality in Europe in 1995. (European Journal of Cancer)
  9. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (European Urology)
  10. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. (Journal of Clinical Oncology)

Their papers